Novel Vaccine Strategy against AIDS Using Cyclic Dodecapeptide Mimicking the Loop Structure of HIV-1 Coreceptor, CCR5
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-03-01
著者
-
三隅 将吾
Dep. Of Pharmaceutical Biochemistry Fac. Of Medical And Pharmaceutical Sciences Kumamoto Univ.
-
Shoji Shozo
Dep. Of Pharmaceutical Biochemistry Fac. Of Medical And Pharmaceutical Sciences Kumamoto Univ.
-
MISUMI Shogo
Department of Pharmaceutical Biochemistry, Faculty of Medical and Pharmaceutical Sciences, Kumamoto
-
TAKAMUNE Nobutoki
Department of Pharmaceutical Biochemistry, Faculty of Medical and Pharmaceutical Sciences, Kumamoto
-
SHOJI Shozo
Department of Pharmaceutical Biochemistry, Faculty of Medical and Pharmaceutical Sciences, Kumamoto
-
Takamune Nobutoki
Dep. Of Pharmaceutical Biochemistry Fac. Of Medical And Pharmaceutical Sciences Kumamoto Univ.
-
Shoji Shozo
Department of Pharmaceutical Biochemistry, Faculty of Life Sciences, Kumamoto University
-
Misumi Shogo
Department of Pharmaceutical Biochemistry, Faculty of Life Sciences, Kumamoto University
関連論文
- 新規環状ペプチドワクチンの開発--HIV-1コレセプターに対する自己抗体誘導によるHIV-1感染阻害 (第1土曜特集 ユニークな創薬ターゲット分子--夢の薬に向かって) -- (難治性疾患治療のための創薬ターゲット分子)
- HIV-1 N-ミリストイル(Myr)-gagタンパク質の細胞内輸送
- MALDI-TOF MASSによる翻訳時・後修飾蛋白質(N-Myristoyl-protein)の修飾部位の化学構造の決定
- Treatment of Breast Cancer Cells with Proteasome Inhibitor Lactacystin Increases the Level of Sensitivity to Cell Death Induced by Human Immunodeficiency Virus Type 1
- Suppression of Multiclade R5 and X4 Human Immunodeficiency Virus Type-1 Infections by a Coreceptor-Based Anti-HIV Strategy
- HIV受容体をターゲットとするHIV感染防御ワクチン : 飲むエイズワクチンを目指して
- Novel Vaccine Strategy against AIDS Using Cyclic Dodecapeptide Mimicking the Loop Structure of HIV-1 Coreceptor, CCR5
- Blocking of Human Immunodeficiency Virus Type-1 Virion Autolysis by Autologous p2^ Peptide
- Suppression of Human Immunodeficiency Virus Type-1 Production by Coexpression of Catalytic-Region-Deleted N-Myristoyltransferase Mutants
- Blocking of Human Immunodeficiency Virus Type-1 Virion Autolysis by Autologous p2gag Peptide